Tecvayli Received FDA Approval for Patients with Relapsed or Refractory Multiple Myeloma.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 38
- Publication type:
- Article
Works matching IS 2475823X AND DT 2022 AND VI 8 AND IP 6
Results: 18
1
2
Libtayo plus Chemotherapy Now FDA Approved for Advanced Lung Cancer without Genomic Alterations.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 37
- Publication type:
- Article
3
Imjudo plus Imfinzi and Chemotherapy FDA Approved for Patients with Metastatic Lung Cancer.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 36
- Publication type:
- Article
4
Imjudo New Immunotherapy FDA Approved with Imfinzi Immunotherapy for Patients with Liver Cancer.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 36
- Publication type:
- Article
5
The Benefits of and Barriers to Participating in Clinical Trials.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 33
- By:
- Publication type:
- Article
6
Elahere FDA Approved for Patients with FRa-Positive, Platinum-Resistant Ovarian Cancer.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 32
- Publication type:
- Article
7
The Burden of Financial Toxicity for LGBTQ People with Cancer.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 28
- By:
- Publication type:
- Article
8
Adcetris Now FDA Approved for Pediatric Patients with Classical Hodgkin Lymphoma.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 27
- Publication type:
- Article
9
Putting the Word "Care" Back into Our Caregivers.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 25
- By:
- Publication type:
- Article
10
Cancer Survivorship Is as Unique as the Survivor.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 24
- Publication type:
- Article
11
Hand Lettering Helped During My Cancer Journey.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 23
- By:
- Publication type:
- Article
12
Rezlidhia FDA Approved for Patients with Relapsed or Refractory Acute Myeloid Leukemia and IDH1 Mutation.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 22
- Publication type:
- Article
13
You Only Live T-W-I-C-E: A Cancer Warrior's Motto.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 20
- By:
- Publication type:
- Article
14
Managing versus Preventing Side Effects: What Is the Difference?
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 18
- By:
- Publication type:
- Article
15
Prostate Cancer 101: What You Need to Know, What to Do, and When to Do It.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 14
- By:
- Publication type:
- Article
16
One Race at a Time: How a Cancer Diagnosis Strengthened My Life as an Accomplished Triathlete.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 11
- By:
- Publication type:
- Article
17
The Shriek I Do Remember.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 9
- By:
- Publication type:
- Article
18
Out with the Fear, In with the New.
- Published in:
- Conquer, 2022, v. 8, n. 6, p. 8
- By:
- Publication type:
- Article